"10.1371_journal.pone.0076690","plos one","2013-11-06T00:00:00Z","Martine van Nierop; Mayke Janssens; Genetic Risk OUtcome of Psychosis (GROUP) Investigators; Richard Bruggeman; Wiepke Cahn; Lieuwe de Haan; René S Kahn; Carin J Meijer; Inez Myin-Germeys; Jim van Os; Durk Wiersma","Maastricht University Medical Centre, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht, The Netherlands; University Medical Center Groningen, Department of Psychiatry, Groningen, The Netherlands; University Medical Center Utrecht, Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, Utrecht, The Netherlands; Academic Medical Centre, University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands; Kings College London, Kings Health Partners, Department of Psychosis Studies, Institute of Psychiatry, London, United Kingdom","¶ Genetic Risk and OUtcome of Psychosis (GROUP) Investigators: Richard Bruggeman, Wiepke Cahn, Lieuwe de Haan, René S. Kahn, Carin J. Meijer, Inez Myin-Germeys, Jim van Os, Durk Wiersma.","The authors received funding from commercial sources: Jansen-Cilag, Eli Lilly and Company, Astra-Zeneca and Lundbeck. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Martine van Nierop","MVN",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
